SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001140361-22-032903
Filing Date
2022-09-09
Accepted
2022-09-09 16:16:48
Documents
18
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A brhc10041760_10qa.htm   iXBRL 10-Q/A 67565
2 EXHIBIT 10.1 brhc10041760_ex10-1.htm EX-10.1 31765
3 EXHIBIT 10.3 brhc10041760_ex10-3.htm EX-10.3 131758
4 EXHIBIT 31.3 brhc10041760_ex31-3.htm EX-31.3 11181
5 EXHIBIT 31.4 brhc10041760_ex31-4.htm EX-31.4 11529
6 EXHIBIT 31.5 brhc10041760_ex31-5.htm EX-31.5 5880
7 EXHIBIT 31.6 brhc10041760_ex31-6.htm EX-31.6 6461
  Complete submission text file 0001140361-22-032903.txt   473152

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA kron-20220630.xsd EX-101.SCH 3868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kron-20220630_lab.xml EX-101.LAB 24117
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kron-20220630_pre.xml EX-101.PRE 17102
12 EXTRACTED XBRL INSTANCE DOCUMENT brhc10041760_10qa_htm.xml XML 5691
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39592 | Film No.: 221236390
SIC: 2834 Pharmaceutical Preparations